Niagen Bioscience, Inc. (NAGE) Form 10-Q Quarterly Reports
Niagen Bioscience, Inc. (NAGE) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NAGE
CIK: 1386570
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerThomas Shoemaker
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001386570-26-000043 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001386570-26-000042 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002885 | View SEC Doc Filr Page |
| 424B5 | 2026-07-10 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-077234 | View SEC Doc Filr Page |
| EFFECT | 2026-07-09 | — | EFFECT Filing | 9999999995-26-002240 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-30 | FORM 4 | 0002042509-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-30 | FORM 4 | 0001834681-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-30 | FORM 4 | 0001417952-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-24 | 8-K | 0001386570-26-000035 | View SEC Doc Filr Page |
| S-3 | 2026-06-29 | — | REGISTRATION STATEMENT | 0001213900-26-072796 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001713918-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001896252-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001923843-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001769529-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001942711-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001381874-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001437237-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001386570-26-000031 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001386570-26-000030 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001386570-26-000024 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001386570-26-000023 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-24 | DEF 14A | 0001386570-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-24 | FORM 4 | 0001417952-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | 8-K | 0001386570-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-03-04 | 8-K | 0001386570-26-000014 | View SEC Doc Filr Page |